THU0085 Depression and its relationships in moroccan patients with rheumatoid arthritis
Background Counter to the course of physical function and structural damage, few studies have addressed psychological health status as the primary outcomes in rheumatoid arthritis (RA) researches. Depression and its predictors among RA patients appear to be unrecognized or under-treated. In African...
Gespeichert in:
Veröffentlicht in: | Annals of the rheumatic diseases 2013-06, Vol.71 (Suppl 3), p.181-182 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 182 |
---|---|
container_issue | Suppl 3 |
container_start_page | 181 |
container_title | Annals of the rheumatic diseases |
container_volume | 71 |
creator | Ibn Yacoub, Y. Amine, B. El kabbaj, S. Hajjaj-Hassouni, N. |
description | Background Counter to the course of physical function and structural damage, few studies have addressed psychological health status as the primary outcomes in rheumatoid arthritis (RA) researches. Depression and its predictors among RA patients appear to be unrecognized or under-treated. In African and Arabic region, there are limited data outlining depression in RA. Objectives We aimed to determine the prevalence of depression in Moroccan patients with RA and to evaluate the disease-related parameters influencing it. Methods 250 consecutive patients with RA were recruited. Patients with previous psychological disorders and significant comorbidities were excluded. The Patient Health Questionnaire depression scale (PHQ-9) was used to measure depressive symptoms. For all patients were collected: socio-demographic characteristics; disease duration; joint pain intensity (visual analogue scale); disease activity (measured clinically using physical examination, biologically and by the disease activity scores (DAS28)); structural damage (by radiographs scored using the Sharp’s method as modified by Van der Heijde); functional disability (by the Health Assessment Questionnaire (HAQ)); extra-articular manifestations; immunological status and treatments. Fatigue was assessed on a 0-100 visual analogue scale (VAS fatigue) and the Arabic version of the generic instrument SF-36 was applied to assess quality of life (QoL). Results There was high prevalence of depressive syndrome among or RA patients: 164 (65.6%) patients have major depressive syndrome and 64 (25.6%) have minor depressive syndrome with a mean total score of PHQ-9 =17.3±8.1indicating a moderate-severe depression. Severe depressive syndrome and higher scores of PHQ-9 were associated with female gender, disease duration, pain intensity, clinical and biological disease activity (DAS28, ESR and CRP), functional disability, structural damage, high levels of RF and ACPAs, higher VAS fatigue scores and impaired physical and mental domains of QoL (for all p≤0.01). Also, patients with decreased levels of education and low socioeconomic status had significantly higher scores of depression (for all p |
doi_str_mv | 10.1136/annrheumdis-2012-eular.2050 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777975389</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008643451</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1659-ee6a656e469c8beb1b9b5ded77b94e4ec2cca65e35a949613ccf1c34c7c9f0bd3</originalsourceid><addsrcrecordid>eNqVkMFOwzAQRC0EEqXwD5F6DthJbMfihAq0QFUuLRJcLMfZKC5tEuxEwI0LP8qX4DYIceXk9ejNzmoQGhF8SkjMzlRV2RK6TW5cGGEShdCtlT2NMMV7aEASlnqZ4X00wBjHYSIYP0RHzq38F6ckHaDHxXTpR_r18XkJjQXnTF0FqsoD07rAwlq1XnClaVxgqmBT21prVQWN16HyyKtpy2B3hGprkwfKtqU1rXHH6KBQawcnP-8QLa-vFuNpOLuf3IwvZmFGGBUhAFOMMkiY0GkGGclERnPIOc9EAgnoyOcxCjFVwt9PYq0LouNEcy0KnOXxEI36vY2tXzpwrVzVna18pCScc8FpnApPnfeUtrVzFgrZWLNR9l0SLLddyj9dym2Xctel3Hbp3WHvNq6Ft1-rss-S8ZhTOX8Yywmds7unWyGJ51nPZ5vVv4K-ASW4ke8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777975389</pqid></control><display><type>article</type><title>THU0085 Depression and its relationships in moroccan patients with rheumatoid arthritis</title><source>BMJ Journals - NESLi2</source><creator>Ibn Yacoub, Y. ; Amine, B. ; El kabbaj, S. ; Hajjaj-Hassouni, N.</creator><creatorcontrib>Ibn Yacoub, Y. ; Amine, B. ; El kabbaj, S. ; Hajjaj-Hassouni, N.</creatorcontrib><description>Background Counter to the course of physical function and structural damage, few studies have addressed psychological health status as the primary outcomes in rheumatoid arthritis (RA) researches. Depression and its predictors among RA patients appear to be unrecognized or under-treated. In African and Arabic region, there are limited data outlining depression in RA. Objectives We aimed to determine the prevalence of depression in Moroccan patients with RA and to evaluate the disease-related parameters influencing it. Methods 250 consecutive patients with RA were recruited. Patients with previous psychological disorders and significant comorbidities were excluded. The Patient Health Questionnaire depression scale (PHQ-9) was used to measure depressive symptoms. For all patients were collected: socio-demographic characteristics; disease duration; joint pain intensity (visual analogue scale); disease activity (measured clinically using physical examination, biologically and by the disease activity scores (DAS28)); structural damage (by radiographs scored using the Sharp’s method as modified by Van der Heijde); functional disability (by the Health Assessment Questionnaire (HAQ)); extra-articular manifestations; immunological status and treatments. Fatigue was assessed on a 0-100 visual analogue scale (VAS fatigue) and the Arabic version of the generic instrument SF-36 was applied to assess quality of life (QoL). Results There was high prevalence of depressive syndrome among or RA patients: 164 (65.6%) patients have major depressive syndrome and 64 (25.6%) have minor depressive syndrome with a mean total score of PHQ-9 =17.3±8.1indicating a moderate-severe depression. Severe depressive syndrome and higher scores of PHQ-9 were associated with female gender, disease duration, pain intensity, clinical and biological disease activity (DAS28, ESR and CRP), functional disability, structural damage, high levels of RF and ACPAs, higher VAS fatigue scores and impaired physical and mental domains of QoL (for all p≤0.01). Also, patients with decreased levels of education and low socioeconomic status had significantly higher scores of depression (for all p<0.001). In multiple regression analysis the main factors associated to depression were: pain intensity (R2=0.525; p=0.001); disease activity (DAS28 (R2=0.495; p=0.003) and CRP (R2=0.658; p<0.001)); functional disability (R2=0.448; p=0.005); ACPAs levels (R2=0.319; p=0.015) and Sharp score (R2=0.377; p=0.012). Conclusions Depression is a major issue among our RA which influenced negatively different aspects of QoL. In our data, depression was associated with low socioeconomic and educational status, pain intensity, disease activity, fatigue, functional disability, ACPAs and structural damage. Depression must be recognized and included in the assessment and management of our patients. The advent of new treatments may improve depressive symptoms through their action on inflammation, pain, fatigue and physical disability. Disclosure of Interest None Declared</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2012-eular.2050</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><ispartof>Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.181-182</ispartof><rights>2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2013 (c) 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/71/Suppl_3/181.3.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/71/Suppl_3/181.3.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3183,23550,27901,27902,77342,77373</link.rule.ids></links><search><creatorcontrib>Ibn Yacoub, Y.</creatorcontrib><creatorcontrib>Amine, B.</creatorcontrib><creatorcontrib>El kabbaj, S.</creatorcontrib><creatorcontrib>Hajjaj-Hassouni, N.</creatorcontrib><title>THU0085 Depression and its relationships in moroccan patients with rheumatoid arthritis</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Background Counter to the course of physical function and structural damage, few studies have addressed psychological health status as the primary outcomes in rheumatoid arthritis (RA) researches. Depression and its predictors among RA patients appear to be unrecognized or under-treated. In African and Arabic region, there are limited data outlining depression in RA. Objectives We aimed to determine the prevalence of depression in Moroccan patients with RA and to evaluate the disease-related parameters influencing it. Methods 250 consecutive patients with RA were recruited. Patients with previous psychological disorders and significant comorbidities were excluded. The Patient Health Questionnaire depression scale (PHQ-9) was used to measure depressive symptoms. For all patients were collected: socio-demographic characteristics; disease duration; joint pain intensity (visual analogue scale); disease activity (measured clinically using physical examination, biologically and by the disease activity scores (DAS28)); structural damage (by radiographs scored using the Sharp’s method as modified by Van der Heijde); functional disability (by the Health Assessment Questionnaire (HAQ)); extra-articular manifestations; immunological status and treatments. Fatigue was assessed on a 0-100 visual analogue scale (VAS fatigue) and the Arabic version of the generic instrument SF-36 was applied to assess quality of life (QoL). Results There was high prevalence of depressive syndrome among or RA patients: 164 (65.6%) patients have major depressive syndrome and 64 (25.6%) have minor depressive syndrome with a mean total score of PHQ-9 =17.3±8.1indicating a moderate-severe depression. Severe depressive syndrome and higher scores of PHQ-9 were associated with female gender, disease duration, pain intensity, clinical and biological disease activity (DAS28, ESR and CRP), functional disability, structural damage, high levels of RF and ACPAs, higher VAS fatigue scores and impaired physical and mental domains of QoL (for all p≤0.01). Also, patients with decreased levels of education and low socioeconomic status had significantly higher scores of depression (for all p<0.001). In multiple regression analysis the main factors associated to depression were: pain intensity (R2=0.525; p=0.001); disease activity (DAS28 (R2=0.495; p=0.003) and CRP (R2=0.658; p<0.001)); functional disability (R2=0.448; p=0.005); ACPAs levels (R2=0.319; p=0.015) and Sharp score (R2=0.377; p=0.012). Conclusions Depression is a major issue among our RA which influenced negatively different aspects of QoL. In our data, depression was associated with low socioeconomic and educational status, pain intensity, disease activity, fatigue, functional disability, ACPAs and structural damage. Depression must be recognized and included in the assessment and management of our patients. The advent of new treatments may improve depressive symptoms through their action on inflammation, pain, fatigue and physical disability. Disclosure of Interest None Declared</description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNqVkMFOwzAQRC0EEqXwD5F6DthJbMfihAq0QFUuLRJcLMfZKC5tEuxEwI0LP8qX4DYIceXk9ejNzmoQGhF8SkjMzlRV2RK6TW5cGGEShdCtlT2NMMV7aEASlnqZ4X00wBjHYSIYP0RHzq38F6ckHaDHxXTpR_r18XkJjQXnTF0FqsoD07rAwlq1XnClaVxgqmBT21prVQWN16HyyKtpy2B3hGprkwfKtqU1rXHH6KBQawcnP-8QLa-vFuNpOLuf3IwvZmFGGBUhAFOMMkiY0GkGGclERnPIOc9EAgnoyOcxCjFVwt9PYq0LouNEcy0KnOXxEI36vY2tXzpwrVzVna18pCScc8FpnApPnfeUtrVzFgrZWLNR9l0SLLddyj9dym2Xctel3Hbp3WHvNq6Ft1-rss-S8ZhTOX8Yywmds7unWyGJ51nPZ5vVv4K-ASW4ke8</recordid><startdate>20130601</startdate><enddate>20130601</enddate><creator>Ibn Yacoub, Y.</creator><creator>Amine, B.</creator><creator>El kabbaj, S.</creator><creator>Hajjaj-Hassouni, N.</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>Elsevier Limited</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20130601</creationdate><title>THU0085 Depression and its relationships in moroccan patients with rheumatoid arthritis</title><author>Ibn Yacoub, Y. ; Amine, B. ; El kabbaj, S. ; Hajjaj-Hassouni, N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1659-ee6a656e469c8beb1b9b5ded77b94e4ec2cca65e35a949613ccf1c34c7c9f0bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ibn Yacoub, Y.</creatorcontrib><creatorcontrib>Amine, B.</creatorcontrib><creatorcontrib>El kabbaj, S.</creatorcontrib><creatorcontrib>Hajjaj-Hassouni, N.</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ibn Yacoub, Y.</au><au>Amine, B.</au><au>El kabbaj, S.</au><au>Hajjaj-Hassouni, N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THU0085 Depression and its relationships in moroccan patients with rheumatoid arthritis</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2013-06-01</date><risdate>2013</risdate><volume>71</volume><issue>Suppl 3</issue><spage>181</spage><epage>182</epage><pages>181-182</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Background Counter to the course of physical function and structural damage, few studies have addressed psychological health status as the primary outcomes in rheumatoid arthritis (RA) researches. Depression and its predictors among RA patients appear to be unrecognized or under-treated. In African and Arabic region, there are limited data outlining depression in RA. Objectives We aimed to determine the prevalence of depression in Moroccan patients with RA and to evaluate the disease-related parameters influencing it. Methods 250 consecutive patients with RA were recruited. Patients with previous psychological disorders and significant comorbidities were excluded. The Patient Health Questionnaire depression scale (PHQ-9) was used to measure depressive symptoms. For all patients were collected: socio-demographic characteristics; disease duration; joint pain intensity (visual analogue scale); disease activity (measured clinically using physical examination, biologically and by the disease activity scores (DAS28)); structural damage (by radiographs scored using the Sharp’s method as modified by Van der Heijde); functional disability (by the Health Assessment Questionnaire (HAQ)); extra-articular manifestations; immunological status and treatments. Fatigue was assessed on a 0-100 visual analogue scale (VAS fatigue) and the Arabic version of the generic instrument SF-36 was applied to assess quality of life (QoL). Results There was high prevalence of depressive syndrome among or RA patients: 164 (65.6%) patients have major depressive syndrome and 64 (25.6%) have minor depressive syndrome with a mean total score of PHQ-9 =17.3±8.1indicating a moderate-severe depression. Severe depressive syndrome and higher scores of PHQ-9 were associated with female gender, disease duration, pain intensity, clinical and biological disease activity (DAS28, ESR and CRP), functional disability, structural damage, high levels of RF and ACPAs, higher VAS fatigue scores and impaired physical and mental domains of QoL (for all p≤0.01). Also, patients with decreased levels of education and low socioeconomic status had significantly higher scores of depression (for all p<0.001). In multiple regression analysis the main factors associated to depression were: pain intensity (R2=0.525; p=0.001); disease activity (DAS28 (R2=0.495; p=0.003) and CRP (R2=0.658; p<0.001)); functional disability (R2=0.448; p=0.005); ACPAs levels (R2=0.319; p=0.015) and Sharp score (R2=0.377; p=0.012). Conclusions Depression is a major issue among our RA which influenced negatively different aspects of QoL. In our data, depression was associated with low socioeconomic and educational status, pain intensity, disease activity, fatigue, functional disability, ACPAs and structural damage. Depression must be recognized and included in the assessment and management of our patients. The advent of new treatments may improve depressive symptoms through their action on inflammation, pain, fatigue and physical disability. Disclosure of Interest None Declared</abstract><cop>Kidlington</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><doi>10.1136/annrheumdis-2012-eular.2050</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4967 |
ispartof | Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.181-182 |
issn | 0003-4967 1468-2060 |
language | eng |
recordid | cdi_proquest_journals_1777975389 |
source | BMJ Journals - NESLi2 |
title | THU0085 Depression and its relationships in moroccan patients with rheumatoid arthritis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T01%3A53%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THU0085%E2%80%85Depression%20and%20its%20relationships%20in%20moroccan%20patients%20with%20rheumatoid%20arthritis&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Ibn%20Yacoub,%20Y.&rft.date=2013-06-01&rft.volume=71&rft.issue=Suppl%203&rft.spage=181&rft.epage=182&rft.pages=181-182&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2012-eular.2050&rft_dat=%3Cproquest_cross%3E4008643451%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777975389&rft_id=info:pmid/&rfr_iscdi=true |